Koru Medical Systems (Nasdaq:KRMD) announced today that it signed a development agreement with a global pharmaceutical company.

The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...

Becton, Dickinson & Co. plans to close its Caesarea Medical Electronics, a producer of infusion pump systems, by June and ...

Systems announced the signing of an agreement with a global pharmaceutical company. The agreement is intended for KORU ...

Symbiq raises the bar for infusion pump technology with an innovative and user-centric approach. With its unique combination of nurse-friendly features, auto-default to safety software ...

KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the ...

BD will close a facility in Caesarea, Israel, by the middle of the year. BD bought the site along with Caesarea Medical ...

KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and ...

"Over the years, there has been an increase in patients that are suffering from chronic conditions," said Kristen Souza, the Nursing Director of Medical ... the outpatient infusion clinic, they ...

A major trial has found a single iron infusion in the third trimester can significantly reduce anaemia in pregnant women and ...

The first phase of the new Cancer Center at Valley Medical Center in Renton opened to patients on Monday, launching the ...